Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 640 publications
CLINICAL OUTCOMES OF NEUROENDOCRINE CARCINOMA OF THE URINARY BLADDER
Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology
Published: January 21, 2026
Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 19, 2026
Penile and scrotal eczema associated with enfortumab vedotin.
Journal: Italian journal of dermatology and venereology
Published: January 14, 2026
Nectin-4 PET for predicting enfortumab vedotin dose-response in urothelial carcinoma.
Journal: Science advances
Published: January 07, 2026
Enfortumab vedotin-related hemorrhagic vesicular eruption managed with dose reduction.
Journal: JAAD case reports
Published: December 25, 2025
Editorial Comment to "Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)".
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 25, 2025
Nectin-4 reduces T cell effector function and is a therapeutic target in pancreatic cancer.
Journal: JCI insight
Published: December 09, 2025
Cost-effectiveness analysis of enfortumab vedotin and pembrolizumab versus chemotherapy for patients with untreated advanced urothelial cancer in the United Kingdom.
Journal: BMJ open
Published: December 08, 2025
Regional Node-positive Bladder Cancer: Therapeutic Decisions Based on Trial Results in Perioperative and Advanced Disease Settings.
Journal: European urology
Published: December 01, 2025
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features.
Journal: Virchows Archiv : an international journal of pathology
Published: November 28, 2025
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project.
Journal: Clinical and experimental medicine
Published: November 25, 2025
Future directions for antibody-drug conjugates in urothelial cancer.
Journal: Expert review of anticancer therapy
Published: November 20, 2025
Last Updated: 02/24/2026